Country: Ástralía
Tungumál: enska
Heimild: APVMA (Australian Pesticides and Veterinary Medicines Authority)
CEPHALEXIN AS CEPHALEXIN MONOHYDRATE
VIRBAC (AUSTRALIA) PTY LTD
cephalexin as monohydrate(600mg/Tb)
ORAL TABLET
CEPHALEXIN AS CEPHALEXIN MONOHYDRATE ANTIBIOTIC Active 600.0 mg/Tb
100 Tabs; 1000 Tabs; 20 Tablets; 300 Tabs; 400 Tabs; 500 Tabs
VM - Veterinary Medicine
DOG | BITCH | CASTRATE | PUPPY
ANTIBIOTIC & RELATED
ENTEROBACTER SPP. | ESCHERICHIA COLI (E. COLI) | INFECTIONS OF SOFT CUTANEOUS TISSUE | INFECTIONS OF THE DIGESTIVE TRACT | INFECTIONS OF THE RESPIRATORY TRACT | INFECTIONS OF THE URINARY TRACTS | KLEBSIELLA SPP. | OSTEOMYELITIS | PROTEUS SPP. | SALMONELLA | SHIGELLA SPP. | STAPHYLOCOCCUS AUREUS | ACUTE RESPIRATORY INFECTIONS | BRONCHISEPTICA | BRONCHITIS | ESCHERICHIA COLI | GROUP D STREPTOCOCCUS | INCLUDING B-LACTAMASE PRODUCIN | KLEBSIELLA SPP. | PHARYNGITIS | PNEUMONIA | PROTEUS SPP. | PSEUDOMONAS AERUGINOSA | SALMONELLOSIS | STAPHYLOCOCCUS SPP. | TONSILLITIS
Poison schedule: 4; Withholding period: WHP: N/A; Host/pest details: DOG: [ENTEROBACTER SPP., ESCHERICHIA COLI (E. COLI), INFECTIONS OF SOFT CUTANEOUS TISSUE, INFECTIONS OF THE DIGESTIVE TRACT, INFECTIONS OF THE RESPIRATORY TRACT, INFECTIONS OF THE URINARY TRACTS, KLEBSIELLA SPP., OSTEOMYELITIS, PROTEUS SPP., SALMONELLA, SHIGELLA SPP., STAPHYLOCOCCUS AUREUS]; Poison schedule: 4; Withholding period: ; Host/pest details: DOG: [ENTEROBACTER SPP., ESCHERICHIA COLI (E. COLI), INFECTIONS OF SOFT CUTANEOUS TISSUE, INFECTIONS OF THE DIGESTIVE TRACT, INFECTIONS OF THE RESPIRATORY TRACT, INFECTIONS OF THE URINARY TRACTS, KLEBSIELLA SPP., OSTEOMYELITIS, PROTEUS SPP., SALMONELLA, SHIGELLA SPP., STAPHYLOCOCCUS AUREUS]; For the treatment of bacteria susceptible to cephalexin.DO NOT use in animals that are hypersensitive to cephalosporins & other penicillins. Some dogs may exhibit nausea, vomiting & diarrhoea.
Registered
2023-07-01
DRAFT LABEL (FRONT PANEL) Page 1 of 8 11.2.03 PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY _RILEXINE_ _ 600_ _ _ CEPHALEXIN ANTIBIOTIC TABLETS FOR DOGS ACTIVE CONSTITUENT: Each tablet contains: 600 mg CEPHALEXIN (as MONOHYDRATE) FOR TREATMENT OF BACTERIAL INFECTIONS SUSCEPTIBLE TO CEPHALEXIN_ _ • INFECTIONS OF SOFT CUTANEOUS TISSUES • RESPIRATORY AND DIGESTIVE INFECTIONS • URINARY INFECTIONS • PREVENTION AND TREATMENT OF OSTEOMYELITIS 1000 TABLETS ( 100 FOIL PACKS OF 10 TABLETS ) Info PEST Verified DRAFT LABEL (FRONT PANEL) Page 2 of 8 11.2.03 PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY _RILEXINE_ _ 600_ _ _ CEPHALEXIN ANTIBIOTIC TABLETS FOR DOGS ACTIVE CONSTITUENT: Each tablet contains: 600 mg CEPHALEXIN (as MONOHYDRATE) FOR TREATMENT OF BACTERIAL INFECTIONS SUSCEPTIBLE TO CEPHALEXIN_ _ • INFECTIONS OF SOFT CUTANEOUS TISSUES • RESPIRATORY AND DIGESTIVE INFECTIONS • URINARY INFECTIONS • PREVENTION AND TREATMENT OF OSTEOMYELITIS 500 TABLETS ( 50 FOIL PACKS OF 10 TABLETS ) DRAFT LABEL (FRONT PANEL) Page 3 of 8 11.2.03 PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY _RILEXINE_ _ 600_ _ _ CEPHALEXIN ANTIBIOTIC TABLETS FOR DOGS ACTIVE CONSTITUENT: Each tablet contains: 600 mg CEPHALEXIN (as MONOHYDRATE) FOR TREATMENT OF BACTERIAL INFECTIONS SUSCEPTIBLE TO CEPHALEXIN_ _ • INFECTIONS OF SOFT CUTANEOUS TISSUES • RESPIRATORY AND DIGESTIVE INFECTIONS • URINARY INFECTIONS • PREVENTION AND TREATMENT OF OSTEOMYELITIS 400 TABLETS ( 40 FOIL PACKS OF 10 TABLETS ) DRAFT LABEL (FRONT PANEL) Page 4 of 8 11.2.03 PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY _RILEXINE_ _ 600_ _ _ CEPHALEXIN ANTIBIOTIC TABLETS FOR DOGS ACTIVE CONSTITUENT: Each tablet contains: 600 mg CEPHALEXIN (as MONOHYDRATE) FOR TREATMENT OF BACTERIAL INFECTIONS SUSCEPTIBLE TO CEPHALEXIN_ _ • INFECTIONS OF SOFT CUTANEOUS TISSUES • Lestu allt skjalið
VIRBAC (AUSTRALIA) PTY. LTD. DOCUMENT NO: RILEXINE CEPHALEXIN TABLETS.DOC REVISION A MATERIAL SAFETY DATA SHEET Product Name: Rilexine Cephalexin Antibiotic Tablets for Dogs and Cats PAGE: 1 OF 4 DATE OF ISSUE 26 JUNE, 2002 O:\Aphs\IT\Infopest\WorkingFiles\NewMSDS\Virbac Word Doc MSDS\Rilexine Cephalexin Tablets.doc 12/09/03 SECTION 1 - IDENTIFICATION OF CHEMICAL PRODUCT AND COMPANY STATEMENT OF HAZARDOUS NATURE This product is classified as: Not classified as hazardous according to the criteria of NOHSC Australia. Not a Dangerous Good according to the Australian Dangerous Goods (ADG) Code. COMPANY: VIRBAC (AUSTRALIA) PTY. LTD ABN 77 003 268 871 ADDRESS 15 Pritchard Place, Peakhurst, NSW 2210, Australia Locked Bag 1000, Peakhurst Delivery Centre, Peakhurst, NSW 2210, Australia TELEPHONE: (02) 9533 2000 or 1800 242 100 FAX: (02) 9533 1522 EMERGENCY PHONE As above during business hours; answering machine after hours SUBSTANCE: Cephalexin is an antibiotic TRADE NAME: Rilexine Cephalexin Antibiotic Tablets for Dogs and Cats PRODUCT CODE: RILEX075; RILEX300; RILEX600; RILEX603; RILEX620 PRODUCT USE: For the treatment in dogs and cats of bacterial infections susceptible to Cephalexin. CREATION DATE: JUNE, 2002 REVISION DATE: JUNE, 2002 SECTION 2 – COMPOSITION/INFORMATION ON INGREDIENTS INGREDIENTS CAS NO CONC,% TWA (MG/M3) STEL (MG/M3) Cephalexin 23325-78-2 40 approx not set not set Other non hazardous ingredients secret to 100 not set not set This is a commercial product whose exact ratio of components may vary slightly. Minor quantities of other non hazardous ingredients are also possible. The TWA exposure value is the average airborne concentration of a particular substance when calculated over a normal 8 hour working day for a 5 day working week. The STEL (Short Term Exposure Limit) is an exposure value that should not be exceeded for more than 15 minutes and should not be repeated for more than 4 times per day. There should be at least 60 minutes between successive exposures at the STEL. The term "peak "is used Lestu allt skjalið